Array BioPharma Inc. (ARRY) financial statements (2021 and earlier)

Company profile

Business Address 3200 WALNUT STREET
BOULDER, CO 80301
State of Incorp. DE
Fiscal Year End June 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

3/31/2019
Q3
12/31/2018
Q2
9/30/2018
Q1
6/30/2018
Q4
3/31/2018
Q3
12/31/2017
Q2
9/30/2017
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:479478415413438419464
Cash and cash equivalents971471311157465295
Short-term investments326330284298365354168
Other undisclosed cash, cash equivalents, and short-term investments56111   
Receivables32224432443027
Inventory, net of allowances, customer advances and progress billings4  22   
Inventory4  22   
Other undisclosed current assets(21)3016(15)554
Total current assets:494531476452488454494
Noncurrent Assets
Property, plant and equipment7777878
Long-term investments and receivables56111111
Long-term investments56111111
Other noncurrent assets101001110
Total noncurrent assets:731889998
TOTAL ASSETS:567549484460497463502
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities33293833252024
Accounts payable910151412119
Accrued liabilities7572323
Employee-related liabilities1614171710712
Debt   18131312
Deferred rent credit111  
Deferred revenue and credits13131417
Contract with customer, liability141311  
Other undisclosed current liabilities39423432342738
Total current liabilities:87848596857491
Noncurrent Liabilities
Long-term debt and lease obligation134133131939593123
Long-term debt, excluding current maturities134133131939593123
Liabilities, other than long-term debt44474951525461
Deferred revenue and credits50515360
Contract with customer, liability384043  
Deferred rent credit555  
Other liabilities1111111
Total noncurrent liabilities:179179180145147147185
Total liabilities:265264265241232221276
Stockholders' equity
Stockholders' equity attributable to parent302285219220265242227
Common stock0000000
Additional paid in capital1,4411,3871,3101,2861,2791,2331,183
Accumulated other comprehensive income (loss)0(0)(0)(0)(1)(1)(0)
Accumulated deficit(1,140)(1,102)(1,091)(1,066)(1,014)(991)(957)
Total stockholders' equity:302285219220265242227
TOTAL LIABILITIES AND EQUITY:567549484460497463502

Income statement (P&L) ($ in millions)

3/31/2019
Q3
12/31/2018
Q2
9/30/2018
Q1
6/30/2018
Q4
3/31/2018
Q3
12/31/2017
Q2
9/30/2017
Q1
Revenues65835735664230
Cost of revenue(1)(1)(0)(16)(18)(14)(12)
Cost of goods and services sold(1)(1)(0)    
Gross profit:64825719492918
Operating expenses(102)(93)(81)(82)(88)(68)(65)
Other undisclosed operating income (loss)110(43)181412
Operating loss:(37)(11)(24)(106)(22)(26)(36)
Nonoperating income (expense)(0)(1)(1)16(1)(8)(2)
Investment income, nonoperating322 111
Interest and debt expense(3)(3)(3) (2)(6)(3)
Loss from continuing operations before income taxes:(40)(14)(27)(90)(25)(41)(41)
Other undisclosed loss from continuing operations   (2)   
Net loss:(40)(14)(27)(92)(25)(41)(41)
Other undisclosed net income attributable to parent33340263
Net loss available to common stockholders, diluted:(37)(11)(25)(52)(23)(34)(38)

Comprehensive Income ($ in millions)

3/31/2019
Q3
12/31/2018
Q2
9/30/2018
Q1
6/30/2018
Q4
3/31/2018
Q3
12/31/2017
Q2
9/30/2017
Q1
Net loss:(40)(14)(27)(92)(25)(41)(41)
Comprehensive loss:(40)(14)(27)(92)(25)(41)(41)
Other undisclosed comprehensive income, net of tax, attributable to parent33340263
Comprehensive loss, net of tax, attributable to parent:(37)(11)(25)(52)(23)(35)(38)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: